Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001501697-26-000069

Executive Chairman sold 47,436 shares at $4.44 ($210,829)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Craig Adam R Executive Chairman 2026-08-12 Sale −47,436 $4.44 $210,829 328,651 D
Open-market sales · 47,436 sh · avg $4.44 · $210,829
Loading xslF345X06/wk-form4_1786651821.xml…